BSE Live
Oct 30, 13:39Prev. Close
832.35
Open Price
831.10
Bid Price (Qty.)
836.65 (48)
Offer Price (Qty.)
838.60 (48)
NSE Live
Oct 30, 13:39Prev. Close
831.90
Open Price
831.90
Bid Price (Qty.)
837.25 (6)
Offer Price (Qty.)
838.00 (45)
| Profit & Loss account of Aarti Pharmalabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 1,744.73 | 1,468.03 | 1,503.36 | 934.66 | 0.00 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 1,744.73 | 1,468.03 | 1,503.36 | 934.66 | 0.00 | |
| Total Operating Revenues | 1,771.35 | 1,502.13 | 1,511.25 | 941.02 | 0.00 | |
| Other Income | 14.49 | 11.01 | 1.28 | 2.51 | 0.00 | |
| Total Revenue | 1,785.84 | 1,513.14 | 1,512.53 | 943.53 | 0.00 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 803.98 | 761.57 | 899.45 | 550.19 | 0.00 | |
| Purchase Of Stock-In Trade | 27.43 | 13.76 | 9.70 | 0.46 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 223.78 | 141.68 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 47.85 | -23.36 | -91.22 | -32.54 | 0.00 | |
| Employee Benefit Expenses | 152.88 | 130.33 | 122.16 | 79.98 | 0.00 | |
| Finance Costs | 25.63 | 16.63 | 20.49 | 11.34 | 0.00 | |
| Depreciation And Amortisation Expenses | 79.06 | 66.01 | 55.77 | 37.23 | 0.00 | |
| Other Expenses | 312.66 | 273.67 | 39.05 | 21.47 | 0.00 | |
| Total Expenses | 1,449.50 | 1,238.62 | 1,279.17 | 809.81 | 0.00 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 336.34 | 274.52 | 233.36 | 133.73 | 0.00 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 336.34 | 274.52 | 233.36 | 133.73 | 0.00 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 62.08 | 49.12 | 52.13 | 22.50 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 22.28 | 27.82 | 9.50 | 4.50 | 0.00 | |
| Tax For Earlier Years | -5.37 | -3.06 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 78.99 | 73.87 | 61.63 | 27.00 | 0.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 257.35 | 200.65 | 171.73 | 106.73 | 0.00 | |
| Profit/Loss From Continuing Operations | 257.35 | 200.65 | 171.73 | 106.73 | 0.00 | |
| Profit/Loss For The Period | 257.35 | 200.65 | 171.73 | 106.73 | 0.00 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 28.39 | 22.14 | 18.95 | 11.78 | -0.18 | |
| Diluted EPS (Rs.) | 28.38 | 22.14 | 18.95 | 11.78 | -0.18 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 215.85 | 160.51 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 566.20 | 323.23 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 39.87 | 27.79 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 31.72 | 18.13 | 18.13 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 100.00 | 60.00 | 40.00 | 0.00 | 0.00 |
22.09.2025
19.09.2025
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
06.02.2025
AARTIPHARM Consolidated December 2024 Net Sales at Rs 537.78 crore, up 19.86% Y-o-Y
06.02.2025
AARTIPHARM Standalone December 2024 Net Sales at Rs 470.95 crore, up 26.25% Y-o-Y